Tag: Blood Bank
ExCellThera And NYBC’s Comprehensive Cell Solutions Enter Manufacturing Agreement
ExCellThera Inc., an advanced clinical stage biotechnology
company delivering molecules and bioengineering solutions to expand stem and
immune cells for therapeutic use, has announced that it has entered into a
manufacturing and collaboration agreement with Comprehensive Cell Solutions
(CCS), a division of New...
Issues In The US Blood Supply Are As Important As The Opioid Crisis Say...
Dr. Brett Giroir, the assistant secretary of health at the
US Department of Health & Human Services, and Bloodworks Northwest
president & CEO Dr. James P. AuBuchon addressed lawmakers and the largest
network of non-profit community blood centers in the USA about...
Orgenesis Reports Cell Therapy Expansion Via Collaboration Agreements Including The Biobank Sector
Orgenesis Inc. a developer, manufacturer and service provider of advanced cell therapies, recently released financial results and provided a business update for the fiscal year ended November 30, 2018. A variety of deals were made during the year including...
Orgenesis and ERYTECH Pharma Partner With The New York Blood Center
Orgenesis Inc., a developer, service provider and manufacturer of advanced cell therapies, has announced that it has entered into a collaboration agreement with the New York Blood Center (NYBC). Under the agreement, NYBC will be responsible for establishing the infrastructure...
The U-Blood Platform Ecosystem By Haier Biomedical
Haier was founded on December 26, 1984, headquartered in China. Under the guidance of the Rendanheyi management philosophy and business philosophy of Zhang Ruimin, Haier has developed into an ecological enterprise led by the Internet of Things. In 2017,...
